Page last updated: 2024-11-01

nialamide and Psoriasis

nialamide has been researched along with Psoriasis in 2 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FLINT, KN1
ORSINI, O1

Other Studies

2 other studies available for nialamide and Psoriasis

ArticleYear
THE USE OF NIALAMIDE IN THE TREATMENT OF PSORIASIS.
    The Practitioner, 1963, Volume: 191

    Topics: Nialamide; Psoriasis

1963
[Treatment of psoriasis with Nialamide].
    Hospital (Rio de Janeiro, Brazil), 1961, Volume: 60

    Topics: Iproniazid; Monoamine Oxidase Inhibitors; Nialamide; Psoriasis

1961